Ear mold for congenital ear malformation: A randomized controlled trial.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
24 Jul 2020
24 Jul 2020
Historique:
entrez:
15
8
2020
pubmed:
15
8
2020
medline:
22
8
2020
Statut:
ppublish
Résumé
Congenital auricular deformities (CAD) are prevalent worldwide. The objective of this study is to investigate the effectiveness and safety of ear molding for children with CAD at their early days. One hundred and nighty children (under 3 days) with CAD will be included in the study. Participants will be randomly allocated to treatment or waiting list group (n = 95). The treatment group will receive ear molding within 3 days after birth for 2 weeks. The control group will receive usual care and receive the same ear molding at 6th week if spontaneously recover is not occur. Physician and parent assessment of improvement, parent's anxiety, depression, and quality of life and adverse events will be measured at baseline, 3rd and 6th week of initial treatment. The primary outcome recovery rate will be compared between groups using Chi square test. Secondary continuous outcomes will be compared using analysis of variance. This study is the first randomized controlled trial to examine the effectiveness, safety and cost-effectiveness of ear molding for CAD comparing with waiting list, to inform clinical decision of CAD treatments and relevant guideline development.
Sections du résumé
BACKGROUND
BACKGROUND
Congenital auricular deformities (CAD) are prevalent worldwide. The objective of this study is to investigate the effectiveness and safety of ear molding for children with CAD at their early days.
METHODS
METHODS
One hundred and nighty children (under 3 days) with CAD will be included in the study. Participants will be randomly allocated to treatment or waiting list group (n = 95). The treatment group will receive ear molding within 3 days after birth for 2 weeks. The control group will receive usual care and receive the same ear molding at 6th week if spontaneously recover is not occur. Physician and parent assessment of improvement, parent's anxiety, depression, and quality of life and adverse events will be measured at baseline, 3rd and 6th week of initial treatment. The primary outcome recovery rate will be compared between groups using Chi square test. Secondary continuous outcomes will be compared using analysis of variance.
DISCUSSION
CONCLUSIONS
This study is the first randomized controlled trial to examine the effectiveness, safety and cost-effectiveness of ear molding for CAD comparing with waiting list, to inform clinical decision of CAD treatments and relevant guideline development.
Identifiants
pubmed: 32791720
doi: 10.1097/MD.0000000000021313
pii: 00005792-202007240-00066
pmc: PMC7387052
doi:
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
e21313Références
J Plast Reconstr Aesthet Surg. 2009 Jun;62(6):727-36
pubmed: 19328756
Ear Nose Throat J. 2017 Sep;96(9):359-360
pubmed: 28931188
Plast Reconstr Surg. 2017 Mar;139(3):681-691
pubmed: 28234847
Arch Otolaryngol Head Neck Surg. 2005 Apr;131(4):326-9
pubmed: 15837901
Plast Reconstr Surg. 2009 Jul;124(1 Suppl):27e-37e
pubmed: 19568137
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
J Craniofac Surg. 2015 Nov;26(8):2309-14
pubmed: 26491919
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
J Plast Reconstr Aesthet Surg. 2009 Jan;62(1):19-27
pubmed: 18952516
Plast Reconstr Surg. 1984 Jan;73(1):38-51
pubmed: 6691074
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 May 7;54(5):330-333
pubmed: 31137090
Clin Plast Surg. 1990 Apr;17(2):383-95
pubmed: 2189652
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Plast Reconstr Surg. 2010 Oct;126(4):1191-1200
pubmed: 20453717
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Br J Plast Surg. 1994 Dec;47(8):575-8
pubmed: 7697288
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2007;6:Doc04
pubmed: 22073080
Patient Relat Outcome Meas. 2016 May 24;7:49-53
pubmed: 27307775
Int J Pediatr Otorhinolaryngol. 2012 Oct;76(10):1406-12
pubmed: 22770593